Now located in a new state of the art facility in South San Francisco, the team leverages its comprehensive end-to-end CMC capabilities to work collaboratively through all phases of CMC development with a primary focus on advancing complex biologic therapies, such as bi-specifics and Client modalities, to human clinical studies and eventual licensure. Preferred : Has hands on experience with executing antibody or antibody-like molecule purification techniques including resin chromatography (affinity, CEX, AEX, MMC ), depth filtration, virus filtration, membrane chromatography, and TFF operations, preferably at pilot or GMP scale .